Evidence Level
Moderate
3 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

Rhodiolife® is a Nektium Pharma branded standardized extract of Rhodiola rosea root, sustainably sourced from high-altitude regions and standardized to ≥3% rosavins and ≥1% salidroside — the active marker ratio used in much of the modern Rhodiola clinical literature. As an adaptogen, Rhodiola rosea has been studied for stress-related fatigue, mild anxiety, generalized anxiety symptoms, depression, mental performance under stress, and endurance, with the bulk of RCTs using extracts standardized to this rosavin/salidroside profile. The Rhodiolife® standardization corresponds to the same compound profile used in the published trials, even though many of those trials used the SHR-5 extract rather than Rhodiolife® specifically.

Studied Dose 200–400 mg/day of standardized Rhodiola rosea extract in stress, anxiety, and fatigue trials; up to 576 mg/day in burnout/fatigue trials. Best taken in the morning to avoid evening stimulation.
Active Compound Standardized Rhodiola rosea root extract — rosavins ≥3% and salidroside ≥1%

Benefits

Stress-related fatigue reduction

Standardized Rhodiola rosea extract supports reduced mental fatigue and improved cognitive performance during periods of high stress, as shown in repeated RCTs in students during exams and shift workers on night duty using the same rosavin/salidroside profile that Rhodiolife® delivers.

Mild anxiety and mood support

Standardized Rhodiola extract supports reductions in self-reported anxiety, stress, anger, confusion, and depression scores in mildly anxious adults, helping people feel calmer and more even-keeled during demanding periods.

Generalized anxiety symptom support

Pilot clinical work in adults with generalized anxiety symptoms has shown clinically meaningful reductions on the Hamilton Anxiety Rating Scale over 10 weeks of daily Rhodiola rosea extract, supporting an anxiolytic role for the adaptogen.

Cognitive performance under stress

Standardized Rhodiola rosea extract supports concentration, processing speed, and self-rated well-being during stress-loaded periods such as exams or night-shift work — benefits attributed to HPA-axis modulation and monoamine support.

Mechanism of action

1

HPA axis modulation

Rosavins and salidroside modulate hypothalamic-pituitary-adrenal axis reactivity, blunting excessive cortisol responses to acute stressors and supporting faster post-stress recovery.

2

Monoamine oxidase modulation

Rhodiola constituents inhibit monoamine oxidase A and B in vitro, reducing breakdown of serotonin, dopamine, and norepinephrine — a plausible mechanism behind the antidepressant and anxiolytic effects.

3

Mitochondrial energy support

Salidroside activates AMPK and supports mitochondrial biogenesis, helping maintain ATP production efficiency under stress and contributing to the anti-fatigue effects observed clinically.

Clinical trials

1
Rhodiola Rosea for Mild Anxiety and Mood

Randomized controlled trial of standardized Rhodiola rosea extract (Vitano®, 2 × 200 mg/day) versus no-treatment control for 14 days in 80 mildly anxious participants. Outcomes: self-reported anxiety, stress, anger, confusion, depression, total mood, and cognition.

80 mildly anxious adults. 14 days.

Rhodiola rosea significantly reduced self-reported anxiety, stress, anger, confusion, and depression, and improved total mood versus the no-treatment control. No cognitive differences were observed. Supports the use of standardized Rhodiola for sub-clinical anxiety symptoms.

2
Rhodiola Rosea for Generalized Anxiety — Pilot

10-week open-label pilot study of standardized Rhodiola rosea extract (Rhodax, 340 mg daily) in 10 adults with generalized anxiety symptoms. Outcome: Hamilton Anxiety Rating Scale (HARS).

10 adults with generalized anxiety symptoms. 10 weeks.

HARS scores decreased significantly from baseline to endpoint, with symptom improvement comparable in magnitude to several first-line treatment trials. Small open-label design limits inference, but supports a clinical signal for Rhodiola in generalized anxiety symptom reduction.

3
Rhodiola Rosea for Stress-Related Fatigue

Randomized double-blind placebo-controlled crossover study of SHR-5 standardized Rhodiola rosea extract (~170 mg, repeated low-dose regimen) in 56 healthy physicians on night duty for two weeks. Outcomes: Fatigue Index across cognitive and perceptive tasks.

56 healthy physicians on night-shift duty. 2 weeks.

Rhodiola rosea significantly reduced overall mental fatigue (Fatigue Index) versus placebo across complex perceptive and cognitive tasks. Foundational evidence for the adaptogen's anti-fatigue and stress-buffering effects in working professionals.

Side effects and drug interactions

Common Potential side effects

Mild dizziness or agitation, particularly at higher doses.
Dry mouth in a small percentage of users.
Stimulant-like effects may interfere with sleep if taken late in the day.
Headache or mild gastrointestinal upset reported occasionally.

Important Drug interactions

MAO inhibitors — additive monoaminergic effects; avoid concurrent use.
SSRIs and SNRIs — theoretical serotonin syndrome risk at high doses; use cautiously.
Stimulant medications — possible additive CNS stimulation; monitor.
CYP3A4 substrates — Rhodiola may modestly affect CYP3A4 in vitro; monitor narrow-window drugs.

Frequently asked questions about Rhodiolife®

What is the recommended dosage of Rhodiolife®?

The clinically studied dose for Rhodiolife® is 200–400 mg/day of standardized Rhodiola rosea extract in stress, anxiety, and fatigue trials; up to 576 mg/day in burnout/fatigue trials. Best taken in the morning to avoid evening stimulation.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Rhodiolife® used for?

Rhodiolife® is studied for stress-related fatigue reduction, mild anxiety and mood support, generalized anxiety symptom support. Standardized Rhodiola rosea extract supports reduced mental fatigue and improved cognitive performance during periods of high stress, as shown in repeated RCTs in students during exams and shift workers on night duty using the same rosavin/salidrosid…

Are there side effects from taking Rhodiolife®?

Reported potential side effects may include: Mild dizziness or agitation, particularly at higher doses. Dry mouth in a small percentage of users. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Rhodiolife® interact with medications?

Known drug interactions may include: MAO inhibitors — additive monoaminergic effects; avoid concurrent use. SSRIs and SNRIs — theoretical serotonin syndrome risk at high doses; use cautiously. Consult a pharmacist or healthcare provider if you take prescription medications.

Is Rhodiolife® good for stress & anxiety?

Yes, Rhodiolife® is researched for Stress & Anxiety support. Standardized Rhodiola rosea extract supports reduced mental fatigue and improved cognitive performance during periods of high stress, as shown in repeated RCTs in students during exams and shift workers on night duty using the same rosavin/salidroside profile that Rhodiolife® del…

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Cropley M, Banks AP, Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother Res. 2015;29(12):1934-9. doi: 10.1002/ptr.5486.PubMedUsed to support: RCT in 80 mildly anxious participants; 14 days of standardized Rhodiola rosea (Vitano®, 2 × 200 mg/day) significantly reduced self-reported anxiety, stress, anger, confusion, and depression and improved total mood versus no-treatment control. Backs Rhodiolife®'s mild-anxiety and mood-support claims through the rosavin/salidroside-standardized class.
  2. Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med. 2008;14(2):175-80. doi: 10.1089/acm.2007.7117.PubMedUsed to support: 10-week open-label pilot in 10 adults with DSM-IV generalized anxiety disorder; standardized R. rosea extract at 340 mg daily produced a significant decrease in mean Hamilton Anxiety Rating Scale scores from baseline. Supports the page's generalized-anxiety symptom claim, with the caveat that this is a small open-label pilot.
  3. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue — a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000;7(5):365-71. doi: 10.1016/S0944-7113(00)80055-0.PubMedUsed to support: Double-blind crossover RCT in 56 healthy physicians on night duty; SHR-5 standardized Rhodiola rosea reduced overall mental fatigue (Fatigue Index) versus placebo across complex perceptive and cognitive tasks. Foundational stress/mental-fatigue evidence for the rosavin/salidroside-standardized Rhodiola class that Rhodiolife® represents.